pubs.acs.org
Bosutinib Stimulates Macrophage Survival, Phagocytosis, and Intracellular Killing of Bacteria
Host-acting compounds are emerging as potential alternatives to combating antibiotic resistance. Here, we show that bosutinib, an FDA-approved chemotherapeutic for treating chronic myelogenous leukemi...